INTRODUCTION
The pituitary hormones, growth hormone (GH) and prolactin, and the placental hormone, placental lactogen (chorionic somatomammotrophin), form a family of proteins with an unusual evolutionary history. They are all between 190 and 199 amino acids long and share sequence homologies indicating that they evolved from a common ancestral gene (Miller & Eberhardt, 1983) . However, amino acid sequence comparisons have indicated remarkable variations in the rate of divergence of these hor¬ mones both within and between species (Wallis, 1981) and, as more gene sequences become available, they are providing useful information for compara¬ tive evolutionary and structure/function studies.
The amino acid sequence for horse GH has been available for some time (Zakin, Poskus, Langton et al. 1976) but not the DNA sequence.
Human, bovine and porcine GH have been produced in large quantities by expressing the corresponding DNA in bacteria and are in widescale use as therapeutic and anabolic agents. Possible uses of recombinant-derived GH in the horse would be (1) stimulating growth and early maturation in foals and young horses, (2) increasing milk production in lactating mares and (3) promoting wound healing, particularly of bone and cartilage. Although porcine and bovine GH would probably be biologically active in the horse, there is a degree of species specificity amongst GH molecules and this, along with the likelihood of immunological reactions, makes it more desirable to use horse GH in assessing the possible applications of recombinant-derived GH in horses.
Here we describe the isolation of a cDNA transcript for horse GH and its expression in Escherichia coli. We chose a secretion vector (PIN-III-lppp~5; Inouye & Inouye, 1985) which secretes A human GH cDNA clone has been successfully expressed using this system to produce correctly processed and correctly folded human GH in large quantities Houghton, Stewart, Doel et al. (1980) as pre¬ viously described (Stewart, Thomson, Leigh & Warwick, 1987e) and analysed by Northern blotting techniques using an ovine GH cDNA probe (Warwick & Wallis, 1984) . Double-stranded cDNA was synthesized from pituitary poly(A) mRNA by the method of Gübler & Hoffman (1983) as previously described (Stewart et al. 1987¿> ) and cloned into pUC8 using Hindlll linkers. The host strain was TGI (Carter, Bedouelle & Winter, 1985) and the resultant libraries were stored in glycerol broth in microtitre trays at -20°C (Gergen, Stern & Wensink, 1979 Inouye, 1985) . Figure 1 illustrates the method of construetion of the horse GH secretion vectors (PIN-III-GH and PIN-III-lppp 5-GH) and details are given in the figure legend.
The oligonucleotide-directed deletion mutagenesis steps (see Fig. 1 (Carter et al. 1985) , JM101 (Messing, Crea & Seeburg, 1981) , W620 (Inouye & Inouye, 1985) [6] [7] [8] and heating at 90°C for 5 min before loading 10-20 pi (Hsiung, Mayne & Becker, 1986 (see below) . Periplasmic fractions were prepared by centrifuging 10 ml cell culture, resuspending the pellet in 0-5 ml ST (20% sucrose and 10 mM Tris-HCl; pH 7-5) and 25 pi 0-5 m EDTA (pH 8), incubating the mixture on ice for 30 min followed by centrifugation for 5 min at 4°C. Finally, the pellet was resuspended by vigorous agitation in 0-5 ml cold distilled H20 (or assay buffer), incubated again on ice for 30 min and centrifuged for 5 min at 4°C ). figure 1. Procedures involved in the preparation of PIN-III-GH and PIN-III-lppp_5-GH, the expression-secretion constructs used to express horse GH in Escherichia coli. Two oligos, an 89 mer and an 81 mer with 12 overlapping complementary bases were annealed and extended (step 1) with the Klenow fragment of DNA polymerase I to give a double-stranded DNA fragment containing EcoRI restriction sites at each end. The 158 bp fragment was cloned into M13mpl9 (step 2), sequenced and ligated to the 3' end (EcoRI site) of the incomplete horse GH cDNA clone, already in M13mpl9 (step 3). Deletion mutagenesis (step 4) was then used to delete the EcoRI site and 30 bases of the original cloning vector (pUC8); the now complete coding sequence for horse GH was ligated into PIN-III-ompA (step 5). The GH cDNA was again excised, along with the ompA signal peptide (Xbal-EcoRI digest), inserted into M13mpl8 and the horse signal peptide deleted (step 6) so that the GH mature peptide sequence was adjacent to and in-frame with the ompA signal peptide (sequence of the junction shown in inset). The ompA-GH fragment was cloned back into the EcoRI-Xbal sites of PIN-III-GH (step 7) and finally into PIN-III-lppp"5 to give PIN-III-lppp-5-GH (step 8).
Aliquots (5-50 pi) of the supernatants were analysed on polyacrylamide gels, in the radioimmunoassay and in the radioreceptor assay. A more sensitive heterologous radioimmunoassay to the one described above, which utilizes 125I-labelled recombinant-derived bovine GH, a guineapig anti-porcine GH serum (Buttle, 1987) (Inouye & Inouye, 1985) . Again, there was no obvious band on the protein gels, either in the total cell lysates or periplasmic fractions (Fig. 3a) . However, Western blots of these gels showed a specific immunoreactive protein band, running with the same mobility as the pituitary-derived horse GH standard in both the total cell lysates and periplasmic fractions of cells harbouring PIN-III-lppp 5-GH (Fig. 3b) . Lysates and periplasmic fractions of cells induced with IPTG showed about a 50% reduction in GH content (Fig. 3b, lanes 3 and 4) Rat GH was the first mammalian GH to be expressed in E. coli but it was produced as a fusion product (ß-lactamase-rat pre-GH) which could not be easily processed to give the natural gene product (Seeburg, Shine, Martial et al. 1978) . Following this, native human GH was successfully expressed in E. coli, with the only modification being the addition of methionine at the N terminus (Goeddel, Heyneker, Hozumi et al. 1979 ). This also indicates that secretion is the ratelimiting factor of the ompA signal peptide expres¬ sion/secretion system. The explanation for the high level of expression obtained with human GH in the absence of IPTG was that the medium probably contained lactose or some other inducer of the lac promoter ); presumably this also accounted for the expression of horse GH (albeit at a low level) in the absence of IPTG.
The Western blot results shown in Fig. 3b pro¬ vided additional evidence for correct cleavage of the bacterial signal peptide. First, the high molecular weight immunoreactive band (24 kDa) present in the total cell lysates (assumed to be the horse GH fusion protein) was absent in the periplasmic fractions and, secondly, the 22 kDa immunoreactive band (assumed to be native horse GH) was strongest in the periplasmic fractions, even though the overall protein content was less than in the total cell lysates (Fig. 3a) .
Additional modifications are underway to obtain higher expression levels of horse GH, but, in the meantime, it is being purified from the existing expression system to begin in-vitro studies on the biological effects of recombinant-derived horse GH on horse tissues.
